Incyte (INCY) Current Assets (2010 - 2026)
Incyte (INCY) posted Current Assets of $5.5 billion for Q1 2026, up 9.16% on a QoQ basis from $5.0 billion in Q4 2025, and up 56.36% year-over-year from $3.5 billion in Q1 2025.
Incyte (INCY) Current Assets (2010 - 2026) Analysis & Trends
Incyte's Current Assets history runs 17 years deep, the most recent figure standing at $5.5 billion for Q1 2026.
- Quarterly Current Assets rose 56.36% year-over-year to $5.5 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.5 billion (up 56.36% YoY) and the FY2025 annual result came in at $5.0 billion, up 55.11% from the prior year.
- Current Assets was $5.5 billion for Q1 2026 at Incyte, up from $5.0 billion in the prior quarter.
- Across five years, Current Assets topped out at $5.5 billion in Q1 2026 and bottomed at $2.6 billion in Q2 2024.
- A 5-year average of $4.0 billion and a median of $4.0 billion in 2023 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2024 — Current Assets sank 39.8% — and 2026, when it jumped 56.36%.
- Incyte's Current Assets stood at $4.1 billion in 2022, then rose by 13.5% to $4.6 billion in 2023, then plunged by 30.27% to $3.2 billion in 2024, then surged by 55.11% to $5.0 billion in 2025, then gained by 9.16% to $5.5 billion in 2026.
- Business Quant data shows INCY's Current Assets at $5.5 billion in Q1 2026, $5.0 billion in Q4 2025, and $4.3 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 289.93 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 73.04 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 3.59 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 6.60 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 11.73 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 18.21 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 521.86 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 1.97 Bn |
| 10 | Incyte | 23.47 Bn | 19.46 Bn | 1.17 Bn | 5.48 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.48 Bn |
| Dec 31, 2025 | 5.02 Bn |
| Sep 30, 2025 | 4.28 Bn |
| Jun 30, 2025 | 3.64 Bn |
| Mar 31, 2025 | 3.51 Bn |
| Dec 31, 2024 | 3.24 Bn |
| Sep 30, 2024 | 2.81 Bn |
| Jun 30, 2024 | 2.57 Bn |
| Mar 31, 2024 | 4.85 Bn |
| Dec 31, 2023 | 4.65 Bn |
| Sep 30, 2023 | 4.40 Bn |
| Jun 30, 2023 | 4.26 Bn |
| Mar 31, 2023 | 3.97 Bn |
| Dec 31, 2022 | 4.09 Bn |
| Sep 30, 2022 | 3.82 Bn |
| Jun 30, 2022 | 3.63 Bn |
| Mar 31, 2022 | 3.29 Bn |
| Dec 31, 2021 | 3.12 Bn |
| Sep 30, 2021 | 2.92 Bn |
| Jun 30, 2021 | 2.62 Bn |